Volume | 1,739,934 |
|
|||||
News | (1) | ||||||
Day High | 3.85 | Low High |
|||||
Day Low | 3.61 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Caribou Biosciences Inc | CRBU | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
3.65 | 3.61 | 3.85 | 3.69 | 3.63 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
10,206 | 1,739,934 | US$ 3.72 | US$ 6,472,342 | - | 3.44 - 8.5899 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:18:37 | 4 | US$ 3.81 | USD |
Caribou Biosciences Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
332.36M | 90.31M | - | 34.48M | -102.07M | -1.13 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Caribou Biosciences News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CRBU Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 4.00 | 4.04 | 3.61 | 3.74 | 1,322,911 | -0.31 | -7.75% |
1 Month | 4.78 | 4.915 | 3.61 | 4.13 | 1,544,586 | -1.09 | -22.80% |
3 Months | 6.89 | 8.33 | 3.61 | 5.48 | 1,585,802 | -3.20 | -46.44% |
6 Months | 3.63 | 8.33 | 3.44 | 5.47 | 1,678,689 | 0.06 | 1.65% |
1 Year | 4.30 | 8.5899 | 3.44 | 5.65 | 1,950,393 | -0.61 | -14.19% |
3 Years | 17.65 | 32.645 | 3.44 | 8.00 | 1,112,413 | -13.96 | -79.09% |
5 Years | 17.65 | 32.645 | 3.44 | 8.00 | 1,112,413 | -13.96 | -79.09% |
Caribou Biosciences Description
Caribou Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. |